PCM
MDT icon

Polymer Capital Management’s Medtronic MDT Stock Holding History

Polymer Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$381K Sell
4,398
-8,065
-65% -$773K 0.04% 511
2025
Q4 		$1.2M Buy
12,463
+6,419
+106% +$624K 0.13% 200
2025
Q3 		$576K Buy
6,044
+361
+6% +$33.2K 0.06% 396
2025
Q2 		$495K Buy
+5,683
New +$482K 0.06% 260

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polymer Capital Management's MDT Position: Q1 2026 in Review

Polymer Capital Management reduced its Medtronic (MDT) stake by 65% in Q1 2026, selling an estimated $773K and leaving 4,398 shares worth $381K. The position accounts for 0.04% of the portfolio, ranked #511.

Polymer Capital Management first reported a position in MDT in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.2M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Polymer Capital Management held 4,398 shares of Medtronic worth $381K as of Q1 2026.
  • Polymer Capital Management sold 8,065 Medtronic shares in Q1 2026, an estimated $773K.
  • Medtronic made up 0.04% of Polymer Capital Management's portfolio in Q1 2026, its #511 holding.
  • Polymer Capital Management first reported a position in Medtronic in Q2 2025 and has held it in 4 quarters since.
  • Polymer Capital Management's Medtronic position peaked at $1.2M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.